Targeted Serum Organic-Acid Profiling Identifies Candidate Metabolic Signatures in Peripartum Cardiomyopathy: A Case-Control Study
International Journal of Molecular Sciences · 20.07.2026 · 27 (14) · 6451
DOI: 10.3390/ijms27146451 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2026. Verfasst von Yasemin Behram Kandemir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Medicine, Istanbul Aydın University, 34295 Istanbul, Turkey. Hauptthemen laut MEDLINE: Peripartum Cardiomyopathy, Metabolomics, Metabolome. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peripartum cardiomyopathy (PPCM) is a potentially life-threatening form of heart failure that occurs toward the end of pregnancy or in the months following delivery. Biomarkers that may support the recognition and characterization of PPCM remain limited. We investigated whether targeted serum organic-acid profiling could identify candidate metabolites associated with PPCM. In this case–control study, serum samples from women with PPCM (n = 40) and healthy controls (n = 40) were analyzed using a targeted organic-acid panel. Log2-transformed metabolite abundances were compared using Welch’s t-test, with Benjamini–Hochberg false discovery rate (FDR) correction correction and Hedges’ g effect sizes. Distributional assumptions were assessed using group-specific Shapiro–Wilk tests, and Mann–Whitney U tests were performed as a non-parametric sensitivity analysis. Homogentisic acid was increased in PPCM (log2fold change (log2FC) = 0.696; FDR q = 9.8 × 10−6), whereas lactic acid was decreased (log2FC = −0.701; FDR q = 0.00773). Both findings remained significant in the Mann–Whitney U sensitivity analysis (BH-FDR q = 5.63 × 10−5 and q = 0.0114, respectively). The best-performing single metabolite showed an area under the receiver operating characteristic curve(AUC) of 0.818 (95% CI, 0.723–0.899). The multivariable model achieved a cross-validated AUC of 0.708 (95% CI, 0.590–0.813), with a sensitivity of 0.800 and a specificity of 0.550. Targeted organic-acid profiling revealed a distinct metabolic signal in PPCM, highlighted by higher homogentisic acid and lower lactic acid levels. These exploratory findings warrant confirmation in larger prospective studies with external validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Faculty of Medicine, Istanbul Aydın University, 34295 Istanbul, Turkey.
- Department of Cardiology, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey.
- Department of Cardiology, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, 63200 Sanliurfa, Turkey.
ORCID-Profile: Ersin Doğanözü
Zitieren
APA
Behram Kandemir, Y., Doğanözü, E., Güntekin, Ü., & Tosun, V. (2026). Targeted Serum Organic-Acid Profiling Identifies Candidate Metabolic Signatures in Peripartum Cardiomyopathy: A Case-Control Study. International Journal of Molecular Sciences, 27(14), 6451. https://doi.org/10.3390/ijms27146451
Vancouver
Behram Kandemir Y, Doğanözü E, Güntekin Ü, Tosun V. Targeted Serum Organic-Acid Profiling Identifies Candidate Metabolic Signatures in Peripartum Cardiomyopathy: A Case-Control Study. International Journal of Molecular Sciences. 2026;27(14):6451. doi:10.3390/ijms27146451
BibTeX
@article{BehramKandemir2026,
author = {Behram Kandemir, Yasemin and Doğanözü, Ersin and Güntekin, Ünal and Tosun, Veysel},
title = {Targeted Serum Organic-Acid Profiling Identifies Candidate Metabolic Signatures in Peripartum Cardiomyopathy: A Case-Control Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6451},
doi = {10.3390/ijms27146451}
}
EUVIMED